Although NDRG1 function is predominantly reported as anti-oncogenic and anti-metastatic, studies also show it to be pro-oncogenic in different cancers such as gastric cancer [77] and HCC [78]. The gene discussed is NDRG1; the disease is hepatocellular carcinoma.